UNCOVERED: Inari medical - The Untold Story

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022

Upgrades

Benzinga · Sep 29, 2022

Inari Medical's Return On Capital Employed Insights

Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.

Benzinga · May 23, 2022

Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus

Inari Medical Inc's (NASDAQ:NARI) Q1 revenue was $86.8 million, up 4% sequentially and 51% Y/Y, beating the consensus of $83.61 million. The increase over the prior year was driven by continued U.S. commercial expansion and new product introductions. The gross margin was 88.5% compared to 91.9% a year ago, modestly lower primarily…

Benzinga · May 5, 2022